Tegaserod
Composition
This formulation contain Tegaserod as active agent
Indications
It is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in women under the age of 65.
Side effects
headache, abdominal pain, diarrhea, nausea, and flatulence
Precautions
used with caution in patients with a history of cardiovascular disease, ischemic heart disease, or stroke
Contraindications
It is contraindicated in patients with a history of myocardial infarction, stroke, transient ischemic attack, or other cardiovascular events
Dosage and administration
directed by a healthcare professional
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai